CTOs on the Move

Tulsa Gamma Ray Inc

www.tulsagammaray.com

 
Tulsa Gamma Ray Inc is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Dental Concepts

Dental Concepts is a Paramus, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Opto IQ

Opto IQ is a Nashua, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

4Catalyzer

At 4Catalyzer we are transforming 21st century medicine by solving today’s most challenging problems – across life science tools, medical devices and therapeutics. We aspire to create significant societal impact and are motivated by the idea that our products will change the lives of people we love. We seek the talent of truly gifted, self-starting and driven individuals to help advance this mission. We provide a stimulating environment, surrounded by brilliant, highly committed individuals who are given both the autonomy and project ownership to solve difficult problems and be the first to publish. Each 4Catalyzer company endeavors to develop technologies that enable unprecedented looks at nature thereby affording the opportunity to do prize-winning science and publish in top-tier journals like Science and Nature. Our advisors have pioneered their fields. Our technology base includes truly novel Devices, Deep Learning and the Cloud. We understand that success requires surrounding yourself with the right people, being at the right place at the right time, and having the resources to get the job done.

Neurolens

Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.

Urocare Products

Urocare Products is a Pomona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.